Monday, August 24, 2026

NRIX 2026-08-24

Nurix Therapeutics: Roche Has Changed The Economics Of The Bull Case

NRIX $2.9B

Equity Eagle 30h ago

Stripe’s “Singularity” and the Divergence from Adyen

ADYEY $39B

MBI Deep Dives 31h ago

The Junk (Mail) Merger Arb

STRR $37M

Triple S Special Situations Investing 34h ago

From X

@irbezek Jul 10

Ian Bezek on X

Citigroup $C ... is it a credit card issuer or an investment bank/broker? I think the market's making the wrong call here, but I could be mistaken. https://t.co/SlQxPnmuGc

@catechwilliams Dec 22

catechwilliams on X

$OXM Very strong holiday selling season based on credit card data & other trackers for core Tommy Bahama and Lilly Pulitzer brands w very minimal promotion or discounts vs modest consensus growth expectations. Stock at 9x EPS, will be providing prelim numbers at ICR in 2 weeks.

@catechwilliams Dec 15

catechwilliams on X

$DAKT Just announced a substantial new project win. Estimated to be $25M in revenue to Daktronics. Yankees, Dodgers, Cubs are among those exploring potential upgrades for next season, all of which are exisiting customers. https://t.co/dcn6TcQNr4

@catechwilliams Dec 13

catechwilliams on X

$CVGW Just delayed earnings release and 10K filing date 1 month, changed filing status. Note the ongoing dispute w Mexican authorities for tax underpayments. That liability is nearly the size of $CVGW mkt cap. The jig may be up.

@catechwilliams Dec 7

catechwilliams on X

$DCGO NYC Controller revokes Mayor Adams' authority to grant emergency order contracts (backdoor, no-bid). The order specifically focuses on DCGO's lucrative "asylum seeker services." NYC = 50% of DCGO revenue. https://t.co/7NUJ0i28Ry

@catechwilliams Dec 5

catechwilliams on X

$NAPA Another senior manager just left. Company doesn't have a CEO, CFO nor apparently any senior members on its finance team now. Doesn't seem optimal given they are integrating a very large acquisition. https://t.co/lfyfru4WUM

@catechwilliams Dec 5

catechwilliams on X

$DAKT Another strong result: sales grew 6%, $0.27 EPS (ex non-cash convert expense) brings LTM to nearly $1.40 or 8x EPS. Don't see a lot of growing, industry leaders w strong FCF profiles at that multiple. No banks cover it, that will change soon. CFO at 2 conferences this week.

@catechwilliams Dec 4

catechwilliams on X

$DKNG Basically just said at the Craig Hallum Conference they are going to miss Q4 guidance. CEO: "literally had the worst stretch of the year, the last few weeks...sometimes that happens where you issue your guidance...So we'll see."